Patents by Inventor Akiko Matsumoto

Akiko Matsumoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240092924
    Abstract: The present invention provides an antibody that binds to an NTCP, capable of inhibiting infection of human hepatocytes with hepatitis B virus (HBV) particles. The present invention also provides an antibody that binds to an NTCP, capable of inhibiting infection of human hepatocytes with hepatitis B virus (HBV) particles, the antibody having a reduced effect on bile acid transport by NTCP.
    Type: Application
    Filed: October 7, 2020
    Publication date: March 21, 2024
    Inventors: Toshitada TAKEMORI, Akiko SUGIMOTO, Michishige HARADA, Mikako SHIROUZU, Takehisa MATSUMOTO, Tomomi SOMEYA, Hiroyuki OSADA, Yushi FUTAMURA, Kunitada SHIMOTOHNO, Hironori NISHITSUJI, Kazuaki CHAYAMA, Daiki MIKI
  • Patent number: 11786444
    Abstract: Provided are monomers useful for dental materials that include a compound in which a core and a specific terminal group are bonded to each other directly or via a linking group, wherein the core is a C1-200 polyvalent organic group having a valence of not less than 3 containing an oxygen atom or a nitrogen atom in which an atom bonded to the terminal group or the linking group is the oxygen atom or the nitrogen atom; the terminal group is a specific (meth)acryloyl group-containing group, a (meth)acryloyl group, a C1-20 hydrocarbon group or a hydrogen atom, and the terminal group needs to meet specific requirements; and the linking group is a specific divalent group, and when the compound contains a plurality of linking groups, the linking groups may be the same as or different from each other. Compositions, dental materials and kits are also provided.
    Type: Grant
    Filed: August 23, 2021
    Date of Patent: October 17, 2023
    Assignee: MITSUI CHEMICALS, INC.
    Inventors: Yoko Kosugi, Akiko Matsumoto, Kazuhiko Yoshinaga
  • Patent number: 11787877
    Abstract: The present invention relates to a monoclonal antibody or antibody fragment thereof as a human IgG antibody including at least one lysine derivative in a constant region of the human IgG antibody; a modified antibody or antibody fragment thereof, wherein the lysine derivative is modified; a nucleic acid including a nucleotide sequence encoding the antibody or antibody fragment thereof; a vector including the nucleic acid; a transformed cell obtained by introducing the vector into a host cell; a method for producing the antibody or antibody fragment thereof; and a composition containing the antibody or antibody fragment thereof.
    Type: Grant
    Filed: December 22, 2020
    Date of Patent: October 17, 2023
    Assignees: RIKEN, KYOWA KIRIN CO., LTD.
    Inventors: Kensaku Sakamoto, Kazumasa Ohtake, Yoshimi Yamaguchi, Shigeyuki Yokoyama, Tatsuo Yanagisawa, Akiko Matsumoto, Akifumi Kato, Yasuhisa Shiraishi, Kaname Kimura, Masakazu Homma
  • Publication number: 20230266337
    Abstract: An object of the present invention is to provide a TARC-containing composition with high storage stability. Provided is a composition including TARC (Thymus and activation-regulated chemokine) and one or more selected from the group consisting of a sugar fatty acid ester-type nonionic surfactant, a polyoxyethylene-polyoxypropylene block copolymer-type nonionic surfactant, and a polyoxyethylene alkylamine-type nonionic surfactant and being in liquid form. The aforementioned object is achieved by the composition.
    Type: Application
    Filed: July 9, 2021
    Publication date: August 24, 2023
    Applicant: SEKISUI MEDICAL CO., LTD.
    Inventors: Akiko MATSUMOTO, Tomoyuki USUI, Yuka SUZUKI, Kengo FUJIMURA
  • Publication number: 20230258657
    Abstract: An object of the present invention is to provide a TARC-containing composition with high storage stability. Provided is a composition including TARC (Thymus and activation-regulated chemokine) and a polymer having 2-methacryloyloxyethyl phosphorylcholine as a structural unit, and being in liquid form. The aforementioned object is achieved by the composition.
    Type: Application
    Filed: July 9, 2021
    Publication date: August 17, 2023
    Applicant: SEKISUI MEDICAL CO., LTD.
    Inventors: Kengo FUJIMURA, Tomoyuki USUI, Yuka SUZUKI, Akiko MATSUMOTO
  • Patent number: 11406571
    Abstract: Provided are monomers useful for dental materials that include a compound in which a core and a specific terminal group are bonded to each other directly or via a linking group, wherein the core is a C1-200 polyvalent organic group having a valence of not less than 3 containing an oxygen atom or a nitrogen atom in which an atom bonded to the terminal group or the linking group is the oxygen atom or the nitrogen atom; the terminal group is a specific (meth)acryloyl group-containing group, a (meth)acryloyl group, a C1-20 hydrocarbon group or a hydrogen atom, and the terminal group needs to meet specific requirements; and the linking group is a specific divalent group, and when the compound contains a plurality of linking groups, the linking groups may be the same as or different from each other. Compositions, dental materials and kits are also provided.
    Type: Grant
    Filed: February 3, 2021
    Date of Patent: August 9, 2022
    Assignee: MITSUI CHEMICALS, INC.
    Inventors: Yoko Kosugi, Akiko Matsumoto, Kazuhiko Yoshinaga
  • Patent number: 11311462
    Abstract: Provided are adhesive monomers for dental materials including compounds represented by the general formula (1) below, in which the core (X) and the terminal group (Y1) are bonded to each other directly or via the linking group (Z): X(Y1)n1a(Z—Y1)n1b(1) wherein n1a represents the number of terminal groups (Y1) directly bonded to the core (X), n1b represents the number of terminal groups (Y1) bonded to the core (X) via the linking group (Z), and the sum of n1a and n1b is equal to the valence of the core (X); the core (X), the linking group (Z) and the terminal group (Y1) are further defined. The adhesive monomers can enhance adhesive strength to the tooth in dental treatment, and impart high mechanical strength to cured products.
    Type: Grant
    Filed: March 29, 2018
    Date of Patent: April 26, 2022
    Assignees: MITSUI CHEMICALS, INC., KULZER GMBH
    Inventors: Yoko Kosugi, Akiko Matsumoto, Kazuhiko Yoshinaga, Michael Gerlach, Maria Lechmann-Dorn, Jutta Schneider, Andreas Utterodt
  • Publication number: 20210378919
    Abstract: Provided are monomers useful for dental materials that include a compound in which a core and a specific terminal group are bonded to each other directly or via a linking group, wherein the core is a C1-200 polyvalent organic group having a valence of not less than 3 containing an oxygen atom or a nitrogen atom in which an atom bonded to the terminal group or the linking group is the oxygen atom or the nitrogen atom; the terminal group is a specific (meth)acryloyl group-containing group, a (meth)acryloyl group, a C1-20 hydrocarbon group or a hydrogen atom, and the terminal group needs to meet specific requirements; and the linking group is a specific divalent group, and when the compound contains a plurality of linking groups, the linking groups may be the same as or different from each other. Compositions, dental materials and kits are also provided.
    Type: Application
    Filed: August 23, 2021
    Publication date: December 9, 2021
    Applicant: MITSUI CHEMICALS, INC.
    Inventors: Yoko KOSUGI, Akiko MATSUMOTO, Kazuhiko YOSHINAGA
  • Publication number: 20210161771
    Abstract: Provided are monomers useful for dental materials that include a compound in which a core and a specific terminal group are bonded to each other directly or via a linking group, wherein the core is a C1-200 polyvalent organic group having a valence of not less than 3 containing an oxygen atom or a nitrogen atom in which an atom bonded to the terminal group or the linking group is the oxygen atom or the nitrogen atom; the terminal group is a specific (meth)acryloyl group-containing group, a (meth)acryloyl group, a C1-20 hydrocarbon group or a hydrogen atom, and the terminal group needs to meet specific requirements; and the linking group is a specific divalent group, and when the compound contains a plurality of linking groups, the linking groups may be the same as or different from each other. Compositions, dental materials and kits are also provided.
    Type: Application
    Filed: February 3, 2021
    Publication date: June 3, 2021
    Applicant: MITSUI CHEMICALS, INC.
    Inventors: Yoko KOSUGI, Akiko MATSUMOTO, Kazuhiko YOSHINAGA
  • Publication number: 20210107997
    Abstract: The present invention relates to a monoclonal antibody or antibody fragment thereof as a human IgG antibody including at least one lysine derivative in a constant region of the human IgG antibody; a modified antibody or antibody fragment thereof, wherein the lysine derivative is modified; a nucleic acid including a nucleotide sequence encoding the antibody or antibody fragment thereof; a vector including the nucleic acid; a transformed cell obtained by introducing the vector into a host cell; a method for producing the antibody or antibody fragment thereof; and a composition containing the antibody or antibody fragment thereof.
    Type: Application
    Filed: December 22, 2020
    Publication date: April 15, 2021
    Applicants: RIKEN, KYOWA KIRIN CO., LTD.
    Inventors: Kensaku Sakamoto, Kazumasa Ohtake, Yoshimi Yamaguchi, Shigeyuki Yokoyama, Tatsuo Yanagisawa, Akiko Matsumoto, Akifumi Kato, Yasuhisa Shiraishi, Kaname Kimura, Masakazu Homma
  • Patent number: 10906990
    Abstract: The present invention relates to a monoclonal antibody or antibody fragment thereof as a human IgG antibody including at least one lysine derivative in a constant region of the human IgG antibody; a modified antibody or antibody fragment thereof, wherein the lysine derivative is modified; a nucleic acid including a nucleotide sequence encoding the antibody or antibody fragment thereof; a vector including the nucleic acid; a transformed cell obtained by introducing the vector into a host cell; a method for producing the antibody or antibody fragment thereof; and a composition containing the antibody or antibody fragment thereof.
    Type: Grant
    Filed: August 18, 2016
    Date of Patent: February 2, 2021
    Assignees: RIKEN, KYOWA KIRIN CO., LTD.
    Inventors: Kensaku Sakamoto, Kazumasa Ohtake, Yoshimi Yamaguchi, Shigeyuki Yokoyama, Tatsuo Yanagisawa, Akiko Matsumoto, Akifumi Kato, Yasuhisa Shiraishi, Kaname Kimura, Masakazu Homma
  • Patent number: 10870715
    Abstract: An object of the invention is to provide a solid polyaluminoxane composition suitably used as a cocatalyst and a catalyst carrier in combination with an olefin oligomerization or polymerization catalyst, without the use of solid inorganic carriers such as silica. The solid polyaluminoxane composition of the invention includes a polyalkylaluminoxane and a trialkylaluminum, and has a solubility in n-hexane at 25° C. of less than 0.50 mol % as measured by a specific method (i), a solubility in toluene at 25° C. of less than 1.0 mol % as measured by a specific method (ii), and a 13 mol % or more molar fraction of alkyl groups derived from the trialkylaluminum moieties relative to the total number of moles of alkyl groups derived from the polyalkylaluminoxane moieties and the alkyl groups derived from the trialkylaluminum moieties as measured with respect to tetrahydrofuran-d8 soluble components by a specific method (iii).
    Type: Grant
    Filed: October 25, 2018
    Date of Patent: December 22, 2020
    Assignee: MITSUI CHEMICALS, INC.
    Inventors: Kou Tsurugi, Shiori Hanada, Atsushi Shibahara, Kazumori Kawamura, Fumiaki Nishino, Yasuyuki Harada, Wataru Yamada, Akiko Matsumoto, Isao Hara, Tatsuya Nakamura, Toshihiro Muroto
  • Publication number: 20190374441
    Abstract: Provided are adhesive materials which exhibit high adhesive strength, and compounds which can be blended with the adhesive materials. The compounds are represented by the general formula: X(Y1)n1, in which the core (X) and the terminal group (Y1) are bonded to each other, n1 represents the number of terminal groups (Y1) bonded to the core (X), and n1 is equal to the valence of the core (X); the core (X) is a C1-200 polyvalent organic group having a valence of not less than 3 containing an oxygen atom or a nitrogen atom in which an atom bonded to the terminal group (Y1) is the oxygen atom or the nitrogen atom; and the terminal group (Y1) is further defined.
    Type: Application
    Filed: March 29, 2018
    Publication date: December 12, 2019
    Applicant: Mitsui Chemicals, Inc.
    Inventors: Yoko KOSUGI, Akiko MATSUMOTO, Kazuhiko YOSHINAGA
  • Publication number: 20190374440
    Abstract: Provided are adhesive monomers for dental materials including compounds represented by the general formula (1) below, in which the core (X) and the terminal group (Y1) are bonded to each other directly or via the linking group (Z): X(Y1)n1a(Z?Y1)n1b(1) wherein n1a represents the number of terminal groups (Y1) directly bonded to the core (X), n1b represents the number of terminal groups (Y1) bonded to the core (X) via the linking group (Z), and the sum of n1a and n1b is equal to the valence of the core (X); the core (X), the linking group (Z) and the terminal group (Y1) are further defined. The adhesive monomers can enhance adhesive strength to the tooth in dental treatment, and impart high mechanical strength to cured products.
    Type: Application
    Filed: March 29, 2018
    Publication date: December 12, 2019
    Applicants: Mitsui Chemicals, Inc., KULZER GMBH
    Inventors: Yoko KOSUGI, Akiko MATSUMOTO, Kazuhiko YOSHINAGA, Michael GERLACH, Maria LECHMANN-DORN, Jutta SCHNEIDER, Andreas UTTERODT
  • Publication number: 20190365610
    Abstract: Provided are monomers useful for dental materials that include a compound in which a core and a specific terminal group are bonded to each other directly or via a linking group, wherein the core is a C1-200 polyvalent organic group having a valence of not less than 3 containing an oxygen atom or a nitrogen atom in which an atom bonded to the terminal group or the linking group is the oxygen atom or the nitrogen atom; the terminal group is a specific (meth)acryloyl group-containing group, a (meth)acryloyl group, a C1-20 hydrocarbon group or a hydrogen atom, and the terminal group needs to meet specific requirements; and the linking group is a specific divalent group, and when the compound contains a plurality of linking groups, the linking groups may be the same as or different from each other. Compositions, dental materials and kits are also provided.
    Type: Application
    Filed: March 29, 2018
    Publication date: December 5, 2019
    Applicant: Mitsui Chemicals, Inc.
    Inventors: Yoko KOSUGI, Akiko MATSUMOTO, Kazuhiko YOSHINAGA
  • Publication number: 20190278568
    Abstract: A non-transitory computer-readable recording medium recording a generation program for causing a computer to execute processing includes: referring to a storage which identifiably stores whether or not an input value is specified for each of a plurality of programs corresponding to a plurality of processing included in a workflow to be created; specifying a first program in which the input value is specified and a second program in which the input value is not specified from among the plurality of programs; determining whether or not the input value of the second program is estimated based on the input value of the first program and a positional relation in the workflow between the specified first program and second program; and setting the input value of the first program as the input value of the second program when determining that the input value of the second program is estimated.
    Type: Application
    Filed: January 31, 2019
    Publication date: September 12, 2019
    Applicant: FUJITSU LIMITED
    Inventors: Naoki Kojima, Yasuo Sezaki, Akiko Matsumoto, Yoshihiro Kimura, Yuji Aoki, Makoto Ikeyama, Shinji Haseo
  • Patent number: 10362939
    Abstract: A fundus analysis apparatus includes a storage, an area setting unit, and a morphological information generating unit. The storage is configured to store OCT information acquired by applying optical coherence tomography to the fundus of an eye. The area setting unit is configured to set a front area corresponding to a front surface of the lamina cribrosa and a rear area corresponding to a rear surface of the lamina cribrosa in the OCT information. The morphological information generating unit is configured to generate morphological information indicating the morphology of the lamina cribrosa based on at least the front area and the rear area.
    Type: Grant
    Filed: August 28, 2015
    Date of Patent: July 30, 2019
    Assignees: TOHOKU UNIVERSITY, KABUSHIKI KAISHA TOPCON
    Inventors: Toru Nakazawa, Kazuko Omodaka, Akiko Matsumoto, Tsutomu Kikawa, Masahiro Akiba
  • Patent number: 10336838
    Abstract: [Problem to be solved] There is provided a process for producing an olefin polymer that is capable of producing an olefin polymer having high heat resistance and high molecular weight with excellent catalytic activity. [Solution to problem] The process for producing an olefin polymer includes a step of polymerizing at least one olefin selected from ethylene and ?-olefins having 4 to 30 carbon atoms in the presence of an olefin polymerization catalyst containing a transition metal compound represented by the general formula [I], the olefin polymer including constituent units derived from ethylene and ?-olefins having 4 to 30 carbon atoms in a total amount between more than 50 mol % and not more than 100 mol %, [in the formula [I], R1, R3 and R5 to R16 are each independently a hydrogen atom, a hydrocarbon group or the like; R2 is a hydrocarbon group or the like; R4 is a hydrogen atom; M is a transition metal of Group IV; Q is a halogen atom or the like; and j is an integer of 1 to 4].
    Type: Grant
    Filed: May 30, 2017
    Date of Patent: July 2, 2019
    Assignee: MITSUI CHEMICALS, INC.
    Inventors: Munehito Funaya, Atsushi Sakuma, Ikuko Ebisawa, Shinsuke Kinoshita, Akiko Matsumoto, Hirokazu Tanaka, Shinya Tanaka
  • Patent number: D860473
    Type: Grant
    Filed: September 21, 2017
    Date of Patent: September 17, 2019
    Assignee: SEKISUI MEDICAL CO., LTD.
    Inventors: Toshiki Kawabe, Akiko Matsumoto, Hiroshi Takahashi
  • Patent number: D860474
    Type: Grant
    Filed: September 21, 2017
    Date of Patent: September 17, 2019
    Assignee: SEKISUI MEDICAL CO., LTD.
    Inventors: Toshiki Kawabe, Akiko Matsumoto, Hiroshi Takahashi